olimesta combi 20 mg+25 mg filmovertrukne tabletter
krka sverige ab - hydrochlorthiazid, olmesartan medoxomil - filmovertrukne tabletter - 20 mg+25 mg
olimesta combi 40 mg+12,5 mg filmovertrukne tabletter
krka sverige ab - hydrochlorthiazid, olmesartan medoxomil - filmovertrukne tabletter - 40 mg+12,5 mg
olimesta combi 40 mg+25 mg filmovertrukne tabletter
krka sverige ab - hydrochlorthiazid, olmesartan medoxomil - filmovertrukne tabletter - 40 mg+25 mg
olmetec plus 20+12,5 mg filmovertrukne tabletter
daiichi sankyo europe gmbh - hydrochlorthiazid, olmesartan medoxomil - filmovertrukne tabletter - 20+12,5 mg
olmetec plus 20+25 mg filmovertrukne tabletter
daiichi sankyo europe gmbh - hydrochlorthiazid, olmesartan medoxomil - filmovertrukne tabletter - 20+25 mg
olmetec plus 40+12,5 mg filmovertrukne tabletter
daiichi sankyo europe gmbh - hydrochlorthiazid, olmesartan medoxomil - filmovertrukne tabletter - 40+12,5 mg
olmetec plus 40+25 mg filmovertrukne tabletter
daiichi sankyo europe gmbh - hydrochlorthiazid, olmesartan medoxomil - filmovertrukne tabletter - 40+25 mg
hydrochlorthiazid "2care4" 25 mg tabletter
2care4 aps - hydrochlorthiazid - tabletter - 25 mg
hydroxyzine "bluefish" 25 mg filmovertrukne tabletter
bluefish pharmaceuticals ab - hydroxyzinhydrochlorid - filmovertrukne tabletter - 25 mg
eucreas
novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.